1. Home
  2. TREX vs NAMS Comparison

TREX vs NAMS Comparison

Compare TREX & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trex Company Inc.

TREX

Trex Company Inc.

HOLD

Current Price

$36.00

Market Cap

3.9B

Sector

N/A

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$28.95

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREX
NAMS
Founded
1996
2019
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.5B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
TREX
NAMS
Price
$36.00
$28.95
Analyst Decision
Buy
Strong Buy
Analyst Count
19
8
Target Price
$52.64
$46.75
AVG Volume (30 Days)
2.0M
862.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.78
N/A
Revenue
$1,174,267,000.00
N/A
Revenue This Year
$5.09
$25.64
Revenue Next Year
$6.16
$530.85
P/E Ratio
$20.70
N/A
Revenue Growth
1.98
N/A
52 Week Low
$29.77
$14.06
52 Week High
$68.78
$42.00

Technical Indicators

Market Signals
Indicator
TREX
NAMS
Relative Strength Index (RSI) 29.26 39.62
Support Level $34.36 $23.48
Resistance Level $35.87 $31.72
Average True Range (ATR) 1.36 1.66
MACD -0.23 -0.14
Stochastic Oscillator 2.22 11.66

Price Performance

Historical Comparison
TREX
NAMS

About TREX Trex Company Inc.

Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: